New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...

The schema newly classified 15.4% of persons without airflow obstruction as having COPD by minor diagnostic category, Surya P ...

Former smokers with COPD reporting higher perceived stress had poorer scores on respiratory health assessments, according to ...

OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, today announced it has ...

CHRONOS 研究首次为 COPD 前驱期或早期阶段的干预提供了临床证据，证实了三联疗法在改善小气道功能和症状方面的有效性，为 COPD 的早期治疗开辟了新路径。同时，哮喘治疗向精准化、个体化方向的转变，也为哮喘患者的管理提供了更科学的策略。这些研究成果不仅丰富了呼吸系统疾病的治疗理论，更有望通过早期干预和精准治疗显著改善患者的生活质量，降低疾病负担，对推动呼吸医学领域的发展具有重要意义。

COPD is a progressive condition, which means that it will typically worsen over time. A doctor will monitor your symptoms with a spirometry test, usually once a year, to determine how quickly the ...

As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...

Participants in both groups underwent training twice daily for five days, with assessments taken before and after the intervention. The tools used included the COPD assessment test, the 6-Minute Walk ...

While exacerbations are more frequent and severe as COPD progresses, patients with COPD may exacerbate for a variety of reasons. For example, pollution, cigarette smoke and upper respiratory tract ...

The GOLD classification is used to determine COPD severity and help form a treatment plan. This is based on the spirometry test result of your FEV1. This is the amount of air you can breathe out ...